← Back to Search

Behavioral Intervention

Smart Healthcare Technology for Alzheimer's Caregiver Support

N/A
Waitlist Available
Led By Karen M Rose, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily through study completion, average of four months
Awards & highlights

Study Summary

This trial aims to develop a solution that monitors a dementia patient's mood and stress, as well as the caregiver's behavior. The goal is to help improve familial interactions related to caregiving, which over time should reduce strain on caregivers.

Who is the study for?
This trial is for men and women aged 60-90 with documented dementia, including Alzheimer's, who live at home and speak English. Caregivers must be over 21, living with the patient, not paid for their care work, have functioning home Wifi, and experience a certain level of stress as measured by a clinical checklist.Check my eligibility
What is being tested?
The study tests a smart healthcare system that monitors mood and stress in both patients with dementia and their caregivers. It uses machine learning to understand interaction dynamics and provides adaptive recommendations to improve caregiver-patient relationships.See study design
What are the potential side effects?
Since this intervention involves monitoring systems rather than medications or invasive procedures, traditional physical side effects are not expected. However, there may be privacy concerns or emotional impacts from constant monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Acoustic Monitoring/Mood Classifier
Change in Caregiver Depression, Anxiety and Stress
Change in Caregiver Loneliness
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dementia/Caregiver DyadExperimental Treatment1 Intervention
All dementia/caregiver dyads will have in-home acoustic monitoring to classify mood and will be provided mindfulness-based stress reduction recommendations via a smart phone.

Find a Location

Who is running the clinical trial?

The University of Tennessee, KnoxvilleOTHER
83 Previous Clinical Trials
18,429 Total Patients Enrolled
Ohio State UniversityLead Sponsor
837 Previous Clinical Trials
507,846 Total Patients Enrolled
University of VirginiaOTHER
759 Previous Clinical Trials
1,245,486 Total Patients Enrolled

Media Library

Mood Monitoring and Behavioral Recommendation System (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04536701 — N/A
Alzheimer's Disease Research Study Groups: Dementia/Caregiver Dyad
Alzheimer's Disease Clinical Trial 2023: Mood Monitoring and Behavioral Recommendation System Highlights & Side Effects. Trial Name: NCT04536701 — N/A
Mood Monitoring and Behavioral Recommendation System (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04536701 — N/A
~24 spots leftby Jun 2025